https://theapba.com/tr/haber/medline-bd-chloraprep-uygulayicilari-iceren-konfor-kitleri-icin-duzeltme-bildirdiTHE APBAtr2026-10-04T20:24:14.244ZMedline, BD ChloraPrep Uygulayıcıları İçeren Konfor Kitleri İçin Düzeltme Bildirdihttps://theapba.com/news-templates/v333/agenda.png?v=3331Medline, BD ChloraPrep Uygulayıcıları İçeren Konfor Kitleri İçin Düzeltme Bildirdihttps://theapba.com/tr/haber/proton-pump-inhibitors-in-invasively-ventilated-patients-with-sars-cov-2-a-substudy-of-the-revise-trialTHE APBAtr2026-10-04T07:44:25.209ZProton Pump Inhibitors in Invasively Ventilated Patients with SARS-CoV-2: A Substudy of the REVISE Trialhttps://theapba.com/news-templates/v333/research.png?v=3331Proton Pump Inhibitors in Invasively Ventilated Patients with SARS-CoV-2: A Substudy of the REVISE Trialhttps://theapba.com/tr/haber/fda-approves-mimrylo-rusfertide-for-polycythemia-vera-first-in-class-therapy-targets-red-blood-cell-overproducTHE APBAtr2026-10-04T06:10:05.486ZFDA Approves Mimrylo (Rusfertide) for Polycythemia Vera: First-in-Class Therapy Targets Red Blood Cell Overproductionhttps://theapba.com/news-templates/v333/agenda.png?v=3331FDA Approves Mimrylo (Rusfertide) for Polycythemia Vera: First-in-Class Therapy Targets Red Blood Cell Overproductionhttps://theapba.com/tr/haber/the-prevalence-of-frontotemporal-dementia-a-systematic-review-and-meta-analysisTHE APBAtr2026-10-04T03:25:05.166ZThe prevalence of frontotemporal dementia: a systematic review and meta-analysishttps://theapba.com/news-templates/v333/research.png?v=3331The prevalence of frontotemporal dementia: a systematic review and meta-analysishttps://theapba.com/tr/haber/european-heart-journal-da-kan-basinci-dusurme-ve-demans-onleme-meta-analizinde-duzeltme-yayinlandiTHE APBAtr2026-10-03T22:20:25.397ZEuropean Heart Journal’da Kan Basıncı Düşürme ve Demans Önleme Meta-Analizinde Düzeltme Yayınlandıhttps://theapba.com/news-templates/v333/academic.png?v=3331European Heart Journal’da Kan Basıncı Düşürme ve Demans Önleme Meta-Analizinde Düzeltme Yayınlandıhttps://theapba.com/tr/haber/daraxonrasib-rmc-6236-for-previously-treated-ras-mutant-non-small-cell-lung-cancer-phase-1-2-trial-resultsTHE APBAtr2026-10-03T05:43:59.713ZDaraxonrasib (RMC-6236) for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer: Phase 1-2 Trial Resultshttps://theapba.com/news-templates/v333/research.png?v=3331Daraxonrasib (RMC-6236) for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer: Phase 1-2 Trial Resultshttps://theapba.com/tr/haber/cdc-mmwr-ana-sayfasi-2024-2026-donemi-halk-sagligi-raporlariTHE APBAtr2026-10-03T03:20:04.985ZCDC MMWR Ana Sayfası: 2024-2026 Dönemi Halk Sağlığı Raporlarıhttps://theapba.com/news-templates/v333/health.png?v=3331CDC MMWR Ana Sayfası: 2024-2026 Dönemi Halk Sağlığı Raporlarıhttps://theapba.com/tr/haber/randomised-controlled-trial-of-a-closed-system-disposable-bronchoscope-sampling-device-rasecal-safety-and-effiTHE APBAtr2026-10-03T02:35:27.199ZRandomised Controlled Trial of a Closed-System Disposable Bronchoscope Sampling Device (RASECAL): Safety and Efficiency versus Standard Containershttps://theapba.com/news-templates/v333/research.png?v=3331Randomised Controlled Trial of a Closed-System Disposable Bronchoscope Sampling Device (RASECAL): Safety and Efficiency versus Standard Containershttps://theapba.com/tr/haber/urtikariyal-vaskulit-vaka-raporu-nejm-de-yayinlandiTHE APBAtr2026-10-03T02:04:21.028ZUrtikariyal Vaskülit Vaka Raporu NEJM'de Yayınlandıhttps://theapba.com/news-templates/v333/clinical.png?v=3331Urtikariyal Vaskülit Vaka Raporu NEJM'de Yayınlandı